DTC
Deep Track Capital Portfolio holdings
AUM
$3.11B
1-Year Return
13.6%
This Quarter Return
+8.61%
1 Year Return
+13.6%
3 Year Return
+265.73%
5 Year Return
–
10 Year Return
–
AUM
$3.13B
AUM Growth
-$216M
(-6.5%)
Cap. Flow
-$396M
Cap. Flow
% of AUM
-12.65%
Top 10 Holdings %
Top 10 Hldgs %
41.39%
Holding
77
New
10
Increased
20
Reduced
24
Closed
8
Top Buys
| 1 |
MBX
MBX Biosciences, Inc. Common Stock
MBX
|
$78.4M |
| 2 |
Apellis Pharmaceuticals
APLS
|
$54.8M |
| 3 |
Immunovant
IMVT
|
$41.7M |
| 4 |
Guardant Health
GH
|
$34.4M |
| 5 |
Kura Oncology
KURA
|
$30.8M |
Top Sells
| 1 |
Amgen
AMGN
|
$180M |
| 2 |
Insmed
INSM
|
$134M |
| 3 |
Alnylam Pharmaceuticals
ALNY
|
$122M |
| 4 |
Travere Therapeutics
TVTX
|
$95.7M |
| 5 |
Axsome Therapeutics
AXSM
|
$89.5M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Praxis Precision Medicines
PRAX
$950M
| – | – |
-389,546
| Closed | -$16.1M |
|
77
Repare Therapeutics
RPTX
$73M
| – | – |
-904,261
| Closed | -$2.98M |
|